Thomas M Suter

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi request reprint Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
    Thomas M Suter
    Swiss Cardiovascular Center, University Hospital Bern, Inselspital, Bern, Switzerland
    J Clin Oncol 25:3859-65. 2007
  2. doi request reprint Cancer drugs and the heart: importance and management
    Thomas M Suter
    Department of Cardiology, Bern University Hospital, 3010 Bern, Switzerland
    Eur Heart J 34:1102-11. 2013
  3. doi request reprint Cancer therapy-associated cardiotoxicity and signaling in the myocardium
    Christian Zuppinger
    Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland
    J Cardiovasc Pharmacol 56:141-6. 2010
  4. doi request reprint Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes
    Manuel Chiusa
    Bern University Hospital, Cardiology, CH 3010 Bern, Switzerland
    J Mol Cell Cardiol 52:1164-75. 2012
  5. doi request reprint Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes
    Polychronis Dimitrakis
    Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital and University of Bern, Bern, Switzerland
    Cell Tissue Res 350:361-72. 2012

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
    Thomas M Suter
    Swiss Cardiovascular Center, University Hospital Bern, Inselspital, Bern, Switzerland
    J Clin Oncol 25:3859-65. 2007
    ..The purpose of this analysis was to investigate trastuzumab-associated cardiac adverse effects in breast cancer patients after completion of (neo)adjuvant chemotherapy with or without radiotherapy...
  2. doi request reprint Cancer drugs and the heart: importance and management
    Thomas M Suter
    Department of Cardiology, Bern University Hospital, 3010 Bern, Switzerland
    Eur Heart J 34:1102-11. 2013
    ..This review discusses concepts for timely diagnosis, intervention, and surveillance of cancer patients undergoing treatment, and provides approaches to clinical uncertainties...
  3. doi request reprint Cancer therapy-associated cardiotoxicity and signaling in the myocardium
    Christian Zuppinger
    Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland
    J Cardiovasc Pharmacol 56:141-6. 2010
    ..Subsequently, the role of endothelial-myocardial communication in maintaining phenotype and survival of adult cardiomyocytes has increasingly been recognized...
  4. doi request reprint Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes
    Manuel Chiusa
    Bern University Hospital, Cardiology, CH 3010 Bern, Switzerland
    J Mol Cell Cardiol 52:1164-75. 2012
    ..In conclusion, these data suggest that cancer therapy with anthracyclines modulates VEGF-A release and its cellular receptors in CMEC and ARVM, and therefore alters paracrine signaling in the myocardium...
  5. doi request reprint Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes
    Polychronis Dimitrakis
    Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital and University of Bern, Bern, Switzerland
    Cell Tissue Res 350:361-72. 2012
    ..This mechanism might contribute to the late cardiotoxicity of anthracyclines by accelerated aging of the postmitotic adult cardiomyocytes and to the susceptibility of the aging heart to anthracycline cancer therapy...